Year Founded
2018
Ownership
Private
Employees
~50
Stage
Preclinical
Modalities
Medical devices

Atmo Biosciences General Information

Developing an ingestible gas-sensing capsule that measures gases directly at source of production in GI tract. Currently conducting pivotal clinical studies for FDA submission for GI motility assessment.

Contact Information

Website
Primary Industry
Medical Devices
Corporate Office
Box Hill, VIC
Australia

Drug Pipeline

No pipeline data available

For full access to Atmo Biosciences's pipeline data

Book a demo

Key Partnerships

Otsuka Pharmaceutical

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Atmo Biosciences Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Atmo Biosciences's complete valuation and funding history, request access »

Atmo Biosciences Investors

Breakthrough Victoria
Investor Type: Venture Capital
Holding: Minority
Otsuka Holdings
Investor Type: Venture Capital
Holding: Minority
AusBiotech
Investor Type: Venture Capital
Holding: Minority
Investor Name
Investor Type
Holding
Investor Name
Investor Type
Holding
You're viewing 3 of 6 investors. Get the full list »